In summary, our data suggest a strong functional link between LASP1, CRKL and BCR-ABL tyrosine kinase, therewith explaining and supporting the bioinformatic data by Yeung et al [9], who identified LASP1 as a new marker for CML progression. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.